CITALOPRAM HYDROBROMID
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract is for the procurement of Citalopram Hydrobromide 20 mg tablets, supplied in bottles of 100 units. The order consists of three bottles under NSN 6505-01-505-4632, with a delivery requirement of five days after receipt of order. The product is an FDA-regulated drug that must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. It carries a non-extendable shelf life of 36 months and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. The agreement is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under solicitation SPE2DP-26-T-4793, with performance located at Fort Stewart. Delivery and inspection are set as FOB Destination with a zero percent quantity variance. The contract incorporates specific technical and quality requirements from the DLA Master List and mandates the removal of government identification from any non-accepted supplies. Approved manufacturers include Mylan Pharmaceuticals Inc, Golden State Medical Supply Inc, and Allergan USA Inc.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
CITALOPRAM HYDROBROMIDE TABLETS. 20 MG, 100'S. UNIT OF ISSUE "BOTTLE"
(100'S). STORE AT 25°C (77°F); EXCURSIONS PERMITTED TO 15 30°C
(59-86°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-6232-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0174-01 ALLERGAN USA INC 4END5 P/N NDC00456-4020-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018092357 0001 BT 3.000
NSN/MATERIAL:6505015054632
DELIVERY (IN DAYS):0005
SPE2DP-26-T-4793
SECTION B
PR: 7018092357 PRLI: 0001 CONT’D
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-505-4632 Quantity: 3 BT Purchase Request: 7018093881QTY: 1 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
